Cancer fighter entering the INK Canadian Insider Index

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Wednesday on INK Ultra Money we highlight a Canadian Healthcare stock that hit a new 52-week high this week. It is pulling back today along with the broad market. However, its fortunes will ultimately be determined by its scientific efforts. We have made this report and video summary freely available to the Canadian Insider community.

We also hear from venerable macro economist Richard Koo describe his policy prescription for a balance sheet recession.

Canadian Insider Club Ultra members have full access to both free and premium content. If you are not an Ultra member, join us or upgrade today.

1. Cancer-fighting Aptose Biosciences to join the INK Canadian Insider Index - INK Research (free).

Cancer-fighting Aptose Bioscience (APS) will be entering the INK Canadian Insider Index on Friday. INK Research takes a look at the company that has been climbing high up the INK Edge rankings. We have made this video summary and report free for the entire Canadian Insider community, but due to network congestion there may be a delay of a few hours before it shows up on INK Ultra Money Free.

 

Trials continue despite COVID-19

 

2. Debt deflation Holy Grail - Real Vision (premium)

 

Real Vision Managing Editor Ed Harrison talks to Richard Koo, Chief Economist at Nomura Research Institute. Koo is famous for his work on balance sheet recessions, a rare type of recession where drastic liquidity injections fail to increase the money supply because they remain trapped in the financial system, as there’s no low demand for loans since companies focus on minimizing debt rather than maximizing profits. He and Harrison discuss this framework in detail, and use it to analyze our current economic crisis the world faces. Koo draws a contrast between the traditional balance sheet recession, where a bursting of a debt-financed bubble causes a collapse in asset prices and an emergence of debt overhang, with what he refers to as a “pandemic recession,” where an exogenous collapse of economic activity leads to disappearing income and a tightening of financial conditions. Koo and Harrison also discuss the various toolkits available to central banks and fiscal authorities worldwide, and Koo shares what he thinks what a sound policy response might look like. Filmed on May 7, 2020, over Skype.

Negative rates are an act of desperation

Every Monday to Friday we present the free Real Vision Daily Briefing. Watch the May 12th edition>>

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).